Characterizing industry payments for FDA-approved AI medical devices
Open Access
- 10 November 2025
- journal article
- Published by Oxford University Press (OUP) in Health Affairs Scholar
- Vol. 3 (12) , qxaf211
Abstract
Introduction: Artificial intelligence-enabled medical devices (AIMDs) are increasing in use, but this growth has raised concerns about inequities in access across well-resourced and under-resourced settings. Little is known about industry–clinician partnerships in the AIMD ecosystem. Methods: We examined the value, specialty distribution, market concentration, and institutional profile of payments made by industry to clinicians for Food and Drug Administration-approved AIMDs using the Open Payments Database. We linked payments to the affiliated hospital of the clinician using the Medicare Provider Data catalog. We performed a regression to explain the association of payments with hospital and county-level factors. Results: We found $59.3 million was spent on payments to 46 315 clinicians for AIMDs between 2017 and 2023, representing an increasing share of total medical device payments over time. We saw high payment concentration in technologically intensive medical specialties and among clinicians affiliated with large, urban teaching hospitals. Conclusion: Industry payments for AIMDs are increasing and concentrated among technology-intensive specialties. Payments are more likely to flow to clinicians affiliated with teaching hospitals that are larger and in non-rural areas. This may reflect or mediate increased AI utilization in these settings. Continued monitoring of payments, transparent reporting, and targeted resource support may be needed to promote equitable access to AIMDs.Keywords
This publication has 39 references indexed in Scilit:
- The role of artificial intelligence in diagnostic neurosurgery: a systematic reviewNeurosurgical Review, 2025
- Generalizability of FDA-Approved AI-Enabled Medical Devices for Clinical UseJAMA Network Open, 2025
- Pursuing Equity With Artificial Intelligence in Health CareJAMA Health Forum, 2025
- Real-Time Prescription Benefit Tool Adoption Among US HospitalsJAMA Health Forum, 2024
- Availability of Evidence for Predictive Machine Learning Algorithms in Primary CareJAMA Network Open, 2024
- Artificial intelligence in neurology: opportunities, challenges, and policy implicationsJournal of Neurology, 2024
- Artificial intelligence in diagnostic and interventional radiology: Where are we now?Diagnostic and Interventional Imaging, 2022
- Applications of Machine Learning in CardiologyCardiology and Therapy, 2022
- Association Between Industry Payments to Physicians and Device Selection in ICD ImplantationJAMA, 2020
- Conflicts of Interest in Medical Technology Markets: Evidence from Orthopedic SurgeryHealth Economics, 2015